EntreMed has produced hard data demonstrating antiangiogenic
activity of its lead compound against the devastating effects of
rheumatoid arthritis (RA). The results pave the way to developing
therapeutics for the cancer and inflammatory...
A toxic group of plant extracts has been found to protect animal
tissue against the lack of blood that occurs in stroke giving rise
to a new direction in the development of stroke treatment.
A new report has blasted pharmaceutical companies for its use of
unscrupulous marketing practices, accusing the drug producers of
misleading physicians of a drug's effectiveness and convincing
consumers of the drug's importance.
SkyePharma used its latest business review meeting to announce the
imminent arrival of a new rheumatoid arthritis (RA) drug formulated
using its novel controlled release drug delivery technology.
Quest Pharmaceutical Services (QPS) has announced the launch of its
new Molecular Biology Services that aims to integrate
pharmacogenomics into drug development programs to deliver more
effective compounds to the market quicker.
Chinese scientists think they might have discovered what activates
the development of Leukaemia signalling a novel direction in which
new therapies can result to treat a disease that afflicts millions
worldwide.
Millipore has unveiled new disposable Tangential Flow Filtration
(TFF) assemblies that reduce validation efforts, increase process
speed and mitigate risks.
The world's largest patient recruitment firm, Synexus Clinical
Research has bagged its first Hungarian company in a bid to exploit
the growing clinical trial opportunities in the emerging Eastern
European market.
Laboratory service provider, LabConnect has announced its
intentions to expand into Central and Eastern Europe by adding
Synevo Medicover Laboratory Services to its LabConnect network,
becoming the first US-based central laboratory...
The world's first drug made from a genetically engineered goat has
been given the thumbs up in Europe after being initially rejected
in February. The decision has reopened the door for "pharming,"
where transgenic animals...
Looking for an edge in both proprietary and off-patent products,
Plethora Solutions has licensed two drug delivery platforms from
Maelor Pharmaceuticals and Metris Therapeutics in the UK.
China's State Food and Drug Administration (SFDA) has authorised
Shanghai Sunve Pharmaceutical and Yichang Changjiang Pharmaceutical
to produce a licensed version of Roche's Tamiflu (oseltamivir
phosphate), the first such...
Vaccine developer Iomai has solidified its position in
transcutaneous immunisation (TCI) by receiving a new US patent
which outlines methods for inducing an immune response to Iomai's
novel skin-patch-based vaccines.
Odyessa Thera has announced it has been granted a US patent for its
single-and multi-colour protein-fragment complementation assays
(PCA), which can be applied to high throughput drug discovery.
A chewing gum to treat Type 2 diabetes and obesity is one step
closer to reality after developers of the technology, Generex,
formed a new partnership with Danish medicinal chewing gum
specialists, Fertin Pharma, to develop the product.
The US Food and Drug Administration (FDA) has urged the pharma
industry to develop preservative-free nasal sprays, however, there
is currently a vacuum of manufacturers that can fulfil such a
requirement.
Testing services and contract manufacturing firm Microtest has
announced it will invest $7.5m (€6m) in new facilities to expand
its offering of pharmaceutical and virology testing services and
fill/finish production capacity.
Biopharmaceutical firm Protherics has acquired a new adjuvant from
Dutch company CoVaccine that it will use for its hypertension
vaccine, hoping to boost antibody production by tenfold.
Biotech company Genzyme Pharmaceuticals and drug delivery firm
Brookwood Pharmaceuticals are now working together to create new
ways of delivering peptide-based drugs.
A recently published report has highlighted the use of antibiotics
in the rearing of fish could promote bacterial resistance leading
to the evolution of resistant strains of bacteria in humans as well
as the fish themselves.
Pliva's venture into the Indian subcontinent received a boost as it
was revealed the Governor of Goa would inaugurate the newly built
research and development facility of Pliva Research, India.
Danish biotechnology firm Novozymes has acquired Delta
Biotechnology from sanofi-aventis, looking to strengthen its
bioprocessing expertise in enzymes and microorganisms with Delta's
ability to manufacture recombinant proteins...
Top international clinical research organisation (CRO) Quintiles is
celebrating after winning two industry awards for its work in the
Asia Pacific region.
GlaxosmithKline (GSK) has agreed to continue its collaboration with
CytoKinetics, which focused towards the mitotic kinesin,
centromere-associated protein E (CENP-E) that has evolved to become
a novel and viable drug target.
PerkinElmer has announced the acquisition of C&A Service
Solutions that will strengthen its OneSource laboratory service by
channelling its range of services into a single outlet.
Preclinical data from Vical's avian flu DNA vaccine program has
resulted in the company coming one step closer to $2.6m (€2m) in
funding for further development of the vaccine under a grant
awarded by the US government.
Laureate Pharma is planning to invest up to $9m (€7.1m) to expand
its biopharmaceutical manufacturing facility in New Jersey with a
new pilot production plant, as it seeks more capacity to cope with
increased demand from clients for...
Schering-Plough has announced plans to adopt a new global model to
standardise its clinical trial operations throughout the world -
aimed at improving trial consistencies, efficiencies and saving
money.
Newly-formed Sentry Logistic Solutions has built its first bridge,
forming a partnership with BioStorage Technologies to offer global
biopharma companies the first cold chain storage/logistics service
that spans all phases of drug...
Using quick disconnect couplings in fluid handling and
manufacturing operations is the safest way to protect brand
integrity by capturing fluid and product data from point of origin
through point of use, according to a top Colbert...
Many said it couldn't be done, but Australian pharma firm
Phosphagenics has developed what it claims is the world's first
transdermal insulin formulation and has received the first signs
that the product may have blockbuster...
Following a recent report that predicted the use of apes in animal
testing would be unavoidable in the future, Spain could become the
first country worldwide to give some primate species fundamental
rights that are granted to human...
Drug companies have been encouraged by recent studies that suggest
that by blocking the binding of transcription factors may be a way
to short-circuit the harmful effects of diseases.
Researchers believe that the effectiveness of from a commonly used
asthma medicine may be compromised by a gene variation, which is
present in around 13 per cent of the city's population.
CureTech has revealed it has wrapped up a deal in which Teva
Pharmaceuticals will invest $6m (€4.7m) in CureTech, for the
development of a revolutionary cancer drug, based on the company's
potential value of $64m.
According to a new report, key trends that are occurring within
pharma-biotech alliances, as well as within biotech-biotech
alliances, are having to grapple with safety concerns and efficacy,
which have made biotech a high-risk area...
Nanogen introduces its latest enterovirus reagent, which employs
hybridisation technology designed to detect
enteroviruses-associated sequences. Enterovirus infections cause a
wide spectrum of diseases and are the most common cause...
Continuing its aggressive entry into Europe's custom manufacturing
arena, Nicholas Piramal (NPIL) has today acquired Pfizer's
manufacturing facility in Northumberland, in a deal that could earn
it more than $350m (€280m)...
Contract packaging firm Testpak has become the first company to
install production equipment that allows it to make Stora Enso's
prize winning child-resistant and senior friendly packaging.
The first ever monoclonal antibody obtained starting from
transgenic plants with the purpose of purifying a human vaccine has
been registered with Cuban authorities, meaning cigars may not be
the only application the country's...
Biotechnology firm SR Pharma has announced a technical breakthrough
in the formulation of siRNA drugs, enabling them to be stored at
room temperature and reconstituted in one simple step, thus
extending shelf life and making administration...
ClinPhone has launched the first electronic solution for clinical
trials that enables central management of drug accountability
across the entire clinical supply chain, from distribution to
destruction.
A new laboratory test that identifies patients who benefit most
from targeted cancer drugs was the talk of the annual meeting of
the American Society of Clinical Oncology (ASCO) as the test's
accuracy is sure to save hundreds...
The first revisions to the layout of drug package inserts in 25
years will come into effect as of June 30 and the Food and Drug
Administration (FDA) has released a draft technical document to
help drug manufacturers incorporate the...
World-leading clinical research organisation (CRO) Covance has
scored what it says is the biggest contract in its history - a
dedicated space agreement worth a minimum of $187m (€149m).
Fonterra, New Zealand's biggest company, has received a green light
from the European Commission to join with Dutch dairy group Campina
to sell lactose to the pharma industry.
Galapagos are to acquire the drug discovery service operations of
Discovery Partners International for $6.4m in a move that cements
Galapagos' BioFocus division as a top three provider in drug
discovery services worldwide.
BASF has announced it has managed to produce the chemical
intermediate N-ethyldiisoproylamine (EDIPA), also known as Huenig's
base, at a purity of at least 99.5 per cent, helping manufacturers
to stay clear from undesirable side...
